|
31 |
Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells
Enthalten in Clinical & experimental metastasis 12.9.2020: 1-12
|
|
|
32 |
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Paramasivam, Nagarajan. - Augsburg : Universität Augsburg, 2019
|
|
|
|
33 |
Biomarker and histopathology evaluation of patients with recurrent glioblastoma treated with galunisertib, lomustine, or the combination of galunisertib and lomustine
Capper, David. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2017
|
|
|
|
34 |
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
Adeberg, Sebastian. - London : BioMed Central, 2016
|
|
|
|
35 |
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Schließer, Maximilian Georg. - Augsburg : Universität Augsburg, 2016
|
|
|
|
36 |
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial - study protocol
Diem, Ricarda. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
37 |
Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion
Nylandsted, Jesper. - Konstanz : Bibliothek der Universität Konstanz, 2009
|
|
|
|
38 |
1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy
Enthalten in Orphanet journal of rare diseases Bd. 16, 20.10.2021, Nr. 1, date:12.2021: 1-16
|
|
|
|
39 |
A H3K27M-targeted vaccine in adults with diffuse midline glioma
Enthalten in Nature medicine Bd. 29, 21.9.2023, Nr. 10, date:10.2023: 2586-2592
|
|
|
|
40 |
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Enthalten in Journal of neuro-oncology Bd. 146, 27.11.2019, Nr. 1, date:1.2020: 79-89
|
|
Administration
